Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

PrognomiQ

1900 Alameda de las Pulgas Suite 100
San Mateo, CA 94403
USA
Website Company Summary Management Team
Management

CEO: Philip Ma (10/31/2020) ; Omid Farokhzad (09/30/2020)
Finance: David L Siewers (08/31/2020)
Board

Outside board: (May no longer be on the board) Tomer Berkowitz (aMoon Partner & CFO)
Company

Business description: PrognomiQ is a healthcare company pursuing the development and commercialization of multi-omics human tests for cancer and other complex diseases. PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. It uses leading edge proteomics technologies, in addition to metabolomics and genomics technologies, to develop multi-omics products to improve human health and deliver first-in-class test products that enable early disease detection and treatment.
Capital

Rounds: 7
Recent Fundings: Mar 2022   Sep 2020
Capital raised: 101.0M
Last Round: 46.0M
Ownership: Private  
VCs include: Invus;  T. Rowe Price Associates;  Fidelity Management and Research CompanyMaverick VenturesEmerson CollectiveaMoon;  Wing VC;  Catalio Capital Management
Corporate investors: Bruker Corporation

Last Tweets


 

Last Mentions


Overview
Record updated: Mar 2022
Sector: Biotech
Year Founded: 2020
Headcount: 26-50 as of Mar 2022
Rounds: 7
Recent Fundings: Mar 2022   Sep 2020
Capital Raised: 101.0M
Last Round: 46.0M
Ownership: Private